Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/11/2018
SIETES contiene 92588 citas

 
 
 1 a 20 de 180 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Girard TD , Exline MC , Carson SS , Hough CL , Rock P , Gong MN , Douglas IS , Malhotra A , Owens RL , Feinstein DJ , Khan B , Pisani MA , Hyzy RC , Schmidt GA , Schweickert WD , Hite RD , Bowton DL , Masica AL , Thompson JL , Chandrasekhar R , Pun BT , Strength C , Boehm LM , Jackson JC , Pandharipande PP , Brummel NE , Hughes CG , Patel MB , Stollings JL , Bernard GR , Dittus RS , Ely EW , for the MIND-USA Investigators. Haloperidol and ziprasidone for treatment of delirium in vritical illness. N Engl J Med 2018:22 de octubre. [Ref.ID 102838]
2.Enlace a cita original Cita con resumen
Garattini S, Bertele V. Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines. Eur J Clin Pharmacol 2018;74:marzo. [Ref.ID 102550]
3. Cita con resumen
4. Cita con resumen
Harrington M, Sigal EV. Opinion: ‘Right-to-try’ law threatens patient safety and rational drug development. STAT Daily Recap 2018:6. [Ref.ID 102467]
6. Cita con resumen
Sevilla-Sánchez D, Molist-Brunet N, Amblàs-Novellas J, Roura-Poch P, Espaulella-Panicot J, Codina-Jané C. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission. Eur J Clin Pharmacol 2017;73:79-89. [Ref.ID 101938]
7. Cita con resumen
Agar MR, Lawlor PG, Quinn S, Draper B, Caplan GA, Rowett D, Sanderson C, Hardy J, Le B, Eckermann S, McCaffrey N, Devilee L, Fazekas B, Hill M, Currow DC. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med 2017;177:34-42. [Ref.ID 101343]
9. Cita con resumen
Anónimo. FDA approves first dronabinol solution for oral use. FDA U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]
10. Cita con resumen
Mitchell SL. Advanced dementia. N Engl J Med 2015;372:2533-40. [Ref.ID 99313]
12.Tiene citas relacionadas Cita con resumen
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S D, Schmidikofer S, Westwood M, Kleijnen J. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015;313:2456-73. [Ref.ID 99308]
13. Cita con resumen
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncology 2015;1:778-84. [Ref.ID 99274]
14. Cita con resumen
Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AH, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness. A randomized clinical trial. JAMA Intern Med 2015;175:691-700. [Ref.ID 99027]
15. Cita con resumen
Zimmermann C, Swami N, Krzyanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014;383:1721-30. [Ref.ID 97608]
16. Cita con resumen
Frechen S, Zoeller A, Ruberg K, Voltz R, Gaerter J. Drug interactions in dying patients: a retrospective analysis of hospice impatients in Germany. Drug Saf 2012;35:745-58. [Ref.ID 93642]
18.Tiene citas relacionadas Cita con resumen
Zhang B, Nilsson ME, Prigerson HG. Factors important to patients' quality of life at the end of life. Arch Intern Med 2012;172:1133-42. [Ref.ID 93586]
19. Cita con resumen
Anónimo. An introduction to patient decision aids. Drug Ther Bull 2012;50:90-2. [Ref.ID 93521]
20. Cita con resumen
Seleccionar todas
 
 1 a 20 de 180 siguiente >>